" class="no-js "lang="en-US"> Manijeh Goldberg - Medtech Alert
Monday, September 22, 2025
Privo Technologies | Pharmtech Focus

Manijeh Goldberg

About Manijeh Goldberg

• Life Science executive with 20-year global experience in R&D, nanotechnology, medical devices, computer science, and business development.

• Strong knowledge of contracts negotiation, regulations, clinical trials, and FDA.

• Founder of two healthcare companies with complex network of hospitals, investors, suppliers, and collaborators.

• “Fire Fighter” who masterfully negotiates, resolves conflicts, removes obstacles, and ensures project completion.

• Biomedical degree from Harvard Medical School, MBA from MIT, and MS in Computer Science and Engineering.

• High energy and can do leader with special interest and investment in entrepreneurship and innovation.

Specialties: Building and leading companies in pharmaceutical, drug delivery, nano technology, health care and medical device fields. Expert in R&D, negotiations, fund raising for start-ups, business development, high technology, building complex information systems, data mining, patient monitoring, billing and automation.

Related Story

Privo Technologies, Inc. Awarded $2M Direct-to-Phase II Contract from the National Cancer Institute for PRV311 Treatment of Cervical Cancer

September 12 2022

Privo Technologies, Inc. (“Privo”, “the Company”) announced today that it has been awarded a $2M Direct-to-Phase II SBIR […]